BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/24/2022 10:56:44 AM | Browse: 773 | Download: 1692
 |
Received |
|
2022-04-25 01:39 |
|
Peer-Review Started |
|
2022-04-25 01:42 |
|
First Decision by Editorial Office Director |
|
2022-05-31 02:14 |
|
Return for Revision |
|
2022-05-31 02:14 |
|
Revised |
|
2022-06-12 21:10 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-08-09 02:55 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-08-11 04:39 |
|
Articles in Press |
|
2022-08-11 04:39 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-08-24 02:32 |
|
Publish the Manuscript Online |
|
2022-09-24 10:56 |
| ISSN |
2220-3249 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Virology |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Anjani Muthyala, Sandeep Sasidharan, Kevin John John, Amos Lal and Ajay K Mishra |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ajay K Mishra, FACP, MBBS, MD, Academic Fellow, Assistant Professor, Department of Cardiology, Saint Vincent Hospital, 123 Summer Street, Worcester, MA 01608, United States. ajay.mishra@stvincenthospital.com |
| Key Words |
SARS-CoV-2; Troponin; Brain natriuretic peptide; Prognosis; Outcomes; Heart failure |
| Core Tip |
Cardiac bioenzymes act as surrogate markers for various cardiovascular complications associated with coronavirus disease 2019 (COVID-19). Cardiac bioenzymes at admission and their serial monitoring can help assess the disease severity and predict mortality in patients with COVID-19. This review summarizes the role of these bioenzymes in diagnosis, prognosis and clinical implications on outcomes of various cardiovascular complications associated with COVID-19. |
| Publish Date |
2022-09-24 10:56 |
| Citation |
Muthyala A, Sasidharan S, John KJ, Lal A, Mishra AK. Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2. World J Virol 2022; 11(5): 375-390 |
| URL |
https://www.wjgnet.com/2220-3249/full/v11/i5/375.htm |
| DOI |
https://dx.doi.org/10.5501/wjv.v11.i5.375 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
